We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$9.59B
AUM Growth
+$2.64B
Cap. Flow
+$1.86B
Cap. Flow %
19.38%
Top 10 Hldgs %
41.45%
Holding
182
New
66
Increased
33
Reduced
26
Closed
49

Sector Composition

Rank Sector Weight
1 Communication Services 18.19%
2 Energy 11.57%
3 Financials 10.79%
4 Healthcare 10.61%
5 Technology 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGS icon
51
Transportadora de Gas del Sur
TGS
$4.48B
$43.1M 0.45%
3,144,432
+1,300,880
+71% +$14.5M
GD icon
52
General Dynamics
GD
$103B
$42.1M 0.44%
224,976
-482,719
-68% -$89.2M
MON
53
DELISTED
Monsanto Co
MON
$38.9M 0.41%
343,700
+31,839
+10% +$3.52M
TTWO icon
54
Take-Two Interactive
TTWO
$46.1B
$34.2M 0.36%
+577,400
New +$32.3M
OIBR.C
55
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$34M 0.35%
5,215,203
-125,253
-2% -$776K
ETN icon
56
Eaton
ETN
$141B
$32.1M 0.33%
+432,500
New +$30.7M
BIVV
57
DELISTED
Bioverativ Inc. Common Stock
BIVV
$31.9M 0.33%
+586,551
New +$28.9M
COL
58
DELISTED
Rockwell Collins
COL
$31.4M 0.33%
+323,200
New +$30.4M
DKS icon
59
Dick's Sporting Goods
DKS
$18.4B
$31.2M 0.33%
+640,700
New +$32.5M
APC
60
DELISTED
Anadarko Petroleum
APC
$30.5M 0.32%
491,800
-1,807,282
-79% -$120M
NOC icon
61
Northrop Grumman
NOC
$76B
$29.8M 0.31%
125,500
+22,900
+22% +$5.44M
ACRS icon
62
Aclaris Therapeutics
ACRS
$715M
$29M 0.3%
971,100
+252,900
+35% +$7.29M
PBYI icon
63
Puma Biotechnology
PBYI
$398M
$28.7M 0.3%
+771,000
New +$28.1M
LLL
64
DELISTED
L3 Technologies, Inc.
LLL
$27.3M 0.28%
165,200
-144,200
-47% -$23.3M
CELG
65
DELISTED
Celgene Corp
CELG
$26.5M 0.28%
213,100
-459,700
-68% -$55M
TGT icon
66
Target
TGT
$66.3B
$25M 0.26%
+452,100
New +$28.1M
CNQ icon
67
Canadian Natural Resources
CNQ
$96.9B
$24.1M 0.25%
+1,503,525
New +$22.8M
BSX icon
68
Boston Scientific
BSX
$68.4B
$22.7M 0.24%
+913,800
New +$22.2M
RL icon
69
Ralph Lauren
RL
$22.4B
$20.4M 0.21%
+249,900
New +$20.6M
AVXS
70
DELISTED
AveXis, Inc. Common Stock
AVXS
$18.9M 0.2%
249,067
+24,067
+11% +$1.49M
SRPT icon
71
Sarepta Therapeutics
SRPT
$1.64B
$18.9M 0.2%
+638,900
New +$19.8M
YPF icon
72
YPF
YPF
$19.7B
$18.4M 0.19%
757,013
-951,605
-56% -$20.5M
QQQ icon
73
PUT
Invesco QQQ Trust
QQQ
$436B
$18.2M 0.19%
+137,500
New +$17.6M
HUM icon
74
Humana
HUM
$43.9B
$18.1M 0.19%
88,000
-283,252
-76% -$58.6M
ARRY
75
DELISTED
Array Biopharma Inc
ARRY
$17.7M 0.18%
+1,983,800
New +$21.1M

Similar funds

PointState Capital's Q1 2017 Portfolio in Review

As of Q1 2017, PointState Capital held 182 positions worth $9.59B, up 38% from $6.95B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

PointState Capital deployed $1.86B of net new capital in Q1 2017, opening 66 new positions and adding to 33 existing holdings. Its largest new stake was DuPont de Nemours: 3,776,539 shares worth $608M.

By sector, the portfolio is most concentrated in Communication Services at 18% of assets, up from 7.4% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was LyondellBasell Industries, an estimated $448M trimmed.

  • PointState Capital's largest Q1 2017 buy was DuPont de Nemours: 3,776,539 shares worth $608M.
  • PointState Capital added most to Meta Platforms (Facebook) in Q1 2017, an estimated $343M increase.
  • PointState Capital's biggest Q1 2017 reduction was LyondellBasell Industries, cutting an estimated $448M.
  • PointState Capital fully exited KeyCorp in Q1 2017, selling an estimated $188M.
  • PointState Capital's ten largest holdings make up 41% of its $9.59B portfolio in Q1 2017.
  • PointState Capital opened 66 new positions and closed 49 in Q1 2017.
  • PointState Capital's portfolio value rose 38% quarter-over-quarter to $9.59B.

Based on PointState Capital's 13F filing for Q1 2017, filed 15 May 2017.